These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 12130509)
1. Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma. Chiriva-Internati M; Wang Z; Salati E; Bumm K; Barlogie B; Lim SH Blood; 2002 Aug; 100(3):961-5. PubMed ID: 12130509 [TBL] [Abstract][Full Text] [Related]
2. Successful generation of sperm protein 17 (Sp17)-specific cytotoxic T lymphocytes from normal donors: implication for tumour-specific adoptive immunotherapy following allogeneic stem cell transplantation for Sp17-positive multiple myeloma. Chiriva-Internati M; Wang Z; Salati E; Wroblewski D; Lim SH Scand J Immunol; 2002 Oct; 56(4):429-33. PubMed ID: 12234264 [TBL] [Abstract][Full Text] [Related]
3. Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk. Chiriva-Internati M; Wang Z; Xue Y; Bumm K; Hahn AB; Lim SH Eur J Immunol; 2001 Aug; 31(8):2277-83. PubMed ID: 11477539 [TBL] [Abstract][Full Text] [Related]
4. Tumor vaccine for ovarian carcinoma targeting sperm protein 17. Chiriva-Internati M; Wang Z; Salati E; Timmins P; Lim SH Cancer; 2002 May; 94(9):2447-53. PubMed ID: 12015770 [TBL] [Abstract][Full Text] [Related]
5. Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy. Wen YJ; Min R; Tricot G; Barlogie B; Yi Q Blood; 2002 May; 99(9):3280-5. PubMed ID: 11964294 [TBL] [Abstract][Full Text] [Related]
6. Umbilical cord blood-derived dendritic cells infected by adenovirus for SP17 expression induce antigen-specific cytotoxic T cells against NSCLC cells. Liu Y; Tian X; Jiang S; Ren X; Liu F; Yang J; Chen Y; Jiang Y Cell Immunol; 2015; 298(1-2):18-24. PubMed ID: 26300426 [TBL] [Abstract][Full Text] [Related]
7. Identification of a sperm protein 17 CTL epitope restricted by HLA-A1. Chiriva-Internati M; Wang Z; Pochopien S; Salati E; Lim SH Int J Cancer; 2003 Dec; 107(5):863-5. PubMed ID: 14566839 [TBL] [Abstract][Full Text] [Related]
8. Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24. Rew SB; Peggs K; Sanjuan I; Pizzey AR; Koishihara Y; Kawai S; Kosaka M; Ozaki S; Chain B; Yong KL Clin Cancer Res; 2005 May; 11(9):3377-84. PubMed ID: 15867238 [TBL] [Abstract][Full Text] [Related]
9. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96. Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569 [TBL] [Abstract][Full Text] [Related]
10. Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells. Wen YJ; Barlogie B; Yi Q Blood; 2001 Mar; 97(6):1750-5. PubMed ID: 11238117 [TBL] [Abstract][Full Text] [Related]
11. Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma. Lim SH; Wang Z; Chiriva-Internati M; Xue Y Blood; 2001 Mar; 97(5):1508-10. PubMed ID: 11222401 [TBL] [Abstract][Full Text] [Related]
12. Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA. Milazzo C; Reichardt VL; Müller MR; Grünebach F; Brossart P Blood; 2003 Feb; 101(3):977-82. PubMed ID: 12393470 [TBL] [Abstract][Full Text] [Related]
13. Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma. Jalili A; Ozaki S; Hara T; Shibata H; Hashimoto T; Abe M; Nishioka Y; Matsumoto T Blood; 2005 Nov; 106(10):3538-45. PubMed ID: 16037388 [TBL] [Abstract][Full Text] [Related]
14. Myeloma cells are highly sensitive to the granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes. Azuma T; Otsuki T; Kuzushima K; Froelich CJ; Fujita S; Yasukawa M Clin Cancer Res; 2004 Nov; 10(21):7402-12. PubMed ID: 15534117 [TBL] [Abstract][Full Text] [Related]
15. The cancer-testis antigen, sperm protein 17, a new biomarker and immunological target in head and neck squamous cell carcinoma. Schutt CA; Mirandola L; Figueroa JA; Nguyen DD; Cordero J; Bumm K; Judson BL; Chiriva-Internati M Oncotarget; 2017 Nov; 8(59):100280-100287. PubMed ID: 29245977 [TBL] [Abstract][Full Text] [Related]
16. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Jayaprabhu S; Pecorelli S; Parham GP; Cannon MJ Clin Cancer Res; 2001 Mar; 7(3 Suppl):804s-810s. PubMed ID: 11300476 [TBL] [Abstract][Full Text] [Related]
17. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180 [TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapy targeting Sp17: when should the laboratory findings be translated to the clinics? Dadabayev AR; Wang Z; Zhang Y; Zhang J; Robinson WR; Lim SH Am J Hematol; 2005 Sep; 80(1):6-11. PubMed ID: 16138340 [TBL] [Abstract][Full Text] [Related]
19. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures. Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317 [TBL] [Abstract][Full Text] [Related]
20. Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3. Yang S; Kittlesen D; Slingluff CL; Vervaert CE; Seigler HF; Darrow TL J Immunol; 2000 Apr; 164(8):4204-11. PubMed ID: 10754316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]